BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3492235)

  • 1. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.
    Francis DA; Batchelor JR; McDonald WI; Hing SN; Dodi IA; Fielder AH; Hern JE; Downie AW
    Brain; 1987 Feb; 110 ( Pt 1)():181-96. PubMed ID: 3492235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA and narcolepsy in a German population.
    Mueller-Eckhardt G; Meier-Ewert K; Schendel DJ; Reinecker FB; Multhoff G; Mueller-Eckhardt C
    Tissue Antigens; 1986 Sep; 28(3):163-9. PubMed ID: 3641479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and C4 in subacute sclerosing panencephalitis.
    Harada F; Onisawa S; Suzuki K; Matsumoto H; Sasazuki T
    Tissue Antigens; 1987 Aug; 30(2):73-5. PubMed ID: 3672494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
    Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
    J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland.
    Francis DA; Batchelor JR; McDonald WI; Dodi IA; Hing SN; Hern JE; Downie AW
    Tissue Antigens; 1987 Jan; 29(1):7-12. PubMed ID: 3590146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HLA system in the Korean population.
    Kim SJ; Nisperos B; Mickelson E; Choi IH; Dahlberg S; Kim JD; Giblett ER; Hansen JA
    Hum Immunol; 1986 Nov; 17(3):259-72. PubMed ID: 3793531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: immunogenetic analyses of sib-pair double case families. II. Studies on the association of multiple sclerosis with C2, C4, BF, C3, C6, and GLO polymorphisms.
    Schröder R; Zander H; Andreas A; Mauff G
    Immunobiology; 1983 Mar; 164(2):160-70. PubMed ID: 6552216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens and complement types in patients with intracranial saccular aneurysms.
    Ostergaard JR; Bruun-Petersen G; Lamm LU
    Tissue Antigens; 1986 Sep; 28(3):176-81. PubMed ID: 3641480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gm allotypes in multiple sclerosis: influence susceptibility in HLA-DQwl-positive patients from the North-East of Scotland.
    Francis DA; Brazier DM; Batchelor JR; McDonald WI; Downie AW; Hern JE
    Clin Immunol Immunopathol; 1986 Dec; 41(3):409-16. PubMed ID: 3780055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
    Wegener S; Falk U; Lakner K; Meyer-Riennecker HJ; Hauptmann G; Uring-Lambert B
    Beitr Infusionsther; 1992; 30():324-31. PubMed ID: 1284726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens in multiple sclerosis of northern Spanish population.
    López-Larrea C; Uría DF; Coto E
    J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotypes bearing HLA-A, -B, and -DR: Bf and C4 genes in rheumatoid arthritis families.
    Sanders PA; Thomson W; Dyer PA; Grennan DM
    Tissue Antigens; 1989 Jan; 33(1):21-9. PubMed ID: 2711369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal profiles in Italian late-onset adrenal hyperplasia correlate with HLA class III polymorphisms.
    Balsamo A; Revelli A; Borelli I; Amoroso A; Cenderelli G; De Sanso G; Mazzola G; Curtoni ES; Zoppetti G; Massobrio M
    Gynecol Endocrinol; 1992 Jun; 6(2):91-8. PubMed ID: 1354409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerosis multiplex in gypsies.
    Kálmán B; Takács K; Gyódi E; Kramer J; Füst G; Tauszik T; Guseo A; Kuntár L; Komoly S; Nagy C
    Acta Neurol Scand; 1991 Sep; 84(3):181-5. PubMed ID: 1683089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis.
    Parkes AB; Darke C; Othman S; Thomas M; Young N; Richards CJ; Hall R; Lazarus JH
    Eur J Endocrinol; 1996 Apr; 134(4):449-53. PubMed ID: 8640296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human C4 polymorphism: pedigree analysis of qualitative, quantitative, and functional parameters as a basis for phenotype interpretations.
    Mauff G; Bender K; Giles CM; Goldmann S; Opferkuch W; Wachauf B
    Hum Genet; 1984; 65(4):362-72. PubMed ID: 6420328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.